AI-generated summary
The authors reviewed existing literature on low-level light therapy as supportive care for breast cancer patients, covering oral mucositis, radiodermatitis, lymphedema, chemotherapy-induced peripheral neuropathy and osteonecrosis of the jaw. They report that the findings suggest low-level light therapy is a promising option for managing treatment-related side effects. The authors also state that appropriate treatment and irradiation parameters still need to be defined for each condition.
- Who or what was studied
- Breast cancer patients receiving treatment, with treatment-related side effects
- Limits stated in the abstract
- The abstract states that appropriate treatment and irradiation parameters still need to be defined for each condition, and it does not report the number of studies included.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Wound healing, Inflammation, Neuropathy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.